{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:26:42Z","timestamp":1791430002840,"version":"4.3.3"},"reference-count":25,"publisher":"Society of Nuclear Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2024,8,28]]},"published-print":{"date-parts":[[2024,11]]},"DOI":"10.2967\/jnumed.124.267913","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T19:10:23Z","timestamp":1727982623000},"page":"1689-1694","source":"Crossref","is-referenced-by-count":10,"title":["Impact of<sup>18<\/sup>F-FES PET\/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer"],"prefix":"10.2967","volume":"65","author":[{"given":"Jeongryul","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewon","family":"Hyung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Byul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Kyung Robyn","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Seok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ho","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyehyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hee","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Bae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Hyuk","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"2025060410401064000_65.11.1689.1","unstructured":"Breast Cancer Facts & Stats. National Breast Cancer Foundation website. https:\/\/www.nationalbreastcancer.org\/breast-cancer-facts. Updated August 1, 2024. Accessed September 5, 2024."},{"key":"2025060410401064000_65.11.1689.2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clbc.2021.01.017","article-title":"Epidemiology of de novo metastatic breast cancer","volume":"21","author":"Daily","year":"2021","journal-title":"Clin Breast Cancer."},{"key":"2025060410401064000_65.11.1689.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60993-8"},{"key":"2025060410401064000_65.11.1689.4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21754"},{"key":"2025060410401064000_65.11.1689.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02309"},{"key":"2025060410401064000_65.11.1689.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31891-8"},{"key":"2025060410401064000_65.11.1689.7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.semnuclmed.2022.03.002","article-title":"16\u03b1-18F-fluoro-17\u03b2-fluoroestradiol (FES): clinical applications for patients with breast cancer","volume":"52","author":"Ulaner","year":"2022","journal-title":"Semin Nucl Med."},{"key":"2025060410401064000_65.11.1689.8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1470-2045(18)30936-7","article-title":"Diagnostic accuracy and safety of 16\u03b1-[18F]fluoro-17\u03b2-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study","volume":"20","author":"Chae","year":"2019","journal-title":"Lancet Oncol."},{"key":"2025060410401064000_65.11.1689.9","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1200\/JCO.22.00400","article-title":"Clinical validity of 16\u03b1-[18F]fluoro-17\u03b2-estradiol positron emission tomography\/computed tomography to assess estrogen receptor status in newly diagnosed metastatic breast cancer","volume":"40","author":"van Geel","year":"2022","journal-title":"J Clin Oncol."},{"key":"2025060410401064000_65.11.1689.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.092734"},{"key":"2025060410401064000_65.11.1689.11","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0096"},{"key":"2025060410401064000_65.11.1689.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.256826"},{"key":"2025060410401064000_65.11.1689.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265420"},{"key":"2025060410401064000_65.11.1689.14","unstructured":"Breast cancer: version 4.2024. NCCN website. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Published July 3, 2024. Accessed September 5, 2024."},{"key":"2025060410401064000_65.11.1689.15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.apradiso.2006.06.016","article-title":"The automatic production of 16\u03b1-[18F]fluoroestradiol using a conventional [18F]FDG module with a disposable cassette system","volume":"65","author":"Oh","year":"2007","journal-title":"Appl Radiat Isot."},{"key":"2025060410401064000_65.11.1689.16","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178368"},{"key":"2025060410401064000_65.11.1689.17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/RLU.0000000000003502","article-title":"Impact of 18F-FDG PET, PET\/CT, and PET\/MRI on staging and management as an initial staging modality in breast cancer: a systematic review and meta-analysis","volume":"46","author":"Han","year":"2021","journal-title":"Clin Nucl Med."},{"key":"2025060410401064000_65.11.1689.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116341"},{"key":"2025060410401064000_65.11.1689.19","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.21037\/qims-20-1364","article-title":"The clinical value of 18F-fluoroestradiol in assisting individualized treatment decision in dual primary malignancies","volume":"11","author":"Yang","year":"2021","journal-title":"Quant Imaging Med Surg."},{"key":"2025060410401064000_65.11.1689.20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.5631"},{"key":"2025060410401064000_65.11.1689.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70292-4"},{"key":"2025060410401064000_65.11.1689.22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2019.10.024","article-title":"Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition","volume":"126","author":"Boers","year":"2020","journal-title":"Eur J Cancer."},{"key":"2025060410401064000_65.11.1689.23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13058-022-01555-7","article-title":"Evaluation of tumour heterogeneity by 18F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment","volume":"24","author":"Liu","year":"2022","journal-title":"Breast Cancer Res."},{"key":"2025060410401064000_65.11.1689.24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s12149-023-01871-8","article-title":"18F-FES and 18F-FDG PET\/CT imaging as a predictive biomarkers for metastatic breast cancer patients undergoing cyclin-dependent 4\/6 kinase inhibitors with endocrine treatment","volume":"37","author":"Liu","year":"2023","journal-title":"Ann Nucl Med."},{"key":"2025060410401064000_65.11.1689.25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.annonc.2024.02.007","article-title":"Early prediction of endocrine responsiveness in ER+\/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT\/PET","volume":"35","author":"Gennari","year":"2024","journal-title":"Ann Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.267913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T17:41:02Z","timestamp":1749058862000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.267913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,1]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.2967\/jnumed.124.267913"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.267913","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}